Caitong International Asset Management Co., LTD Immatics N.V. Transaction History
Caitong International Asset Management Co., LTD
- $134 Billion
- Q1 2025
A detailed history of Caitong International Asset Management Co., LTD transactions in Immatics N.V. stock. As of the latest transaction made, Caitong International Asset Management Co., LTD holds 374 shares of IMTX stock, worth $1,754. This represents 0.0% of its overall portfolio holdings.
Number of Shares
374Holding current value
$1,754% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding IMTX
# of Institutions
82Shares Held
91.5MCall Options Held
201KPut Options Held
109K-
T. Rowe Price Investment Management, Inc. Baltimore, MD14.7MShares$68.8 Million0.04% of portfolio
-
Perceptive Advisors LLC New York, NY9.38MShares$44 Million1.77% of portfolio
-
Suvretta Capital Management, LLC New York, NY9.14MShares$42.8 Million1.8% of portfolio
-
Wellington Management Group LLP Boston, MA8.58MShares$40.3 Million0.01% of portfolio
-
Baker Bros. Advisors LP New York, NY7.28MShares$34.1 Million0.39% of portfolio
About Immatics N.V.
- Ticker IMTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,227,000
- Market Cap $358M
- Description
- Immatics N.V., a clinical-stage biopharmaceutical company, focuses on the discovery and development of T cell receptor (TCR) based immunotherapies for the treatment of cancer in the United States. The company is developing targeted immunotherapies with a focus on treating solid tumors through two distinct treatment modalities, such as adoptive c...